In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently undervalued, has posted a ...

Q4 2024 Earnings Call Transcript January 28, 2025 Operator: Good afternoon, and welcome to the Alexandria Real Estate ...

Good afternoon, and welcome to the Alexandria Real Estate Equities fourth-quarter and year end 2024 conference call. (Operator Instructions) Please note this event is being recorded. I would now like ...

TD Cowen analyst Ryan Langston maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $391.00. The company’s ...

Who else could be on the move between now and the trade deadline? We'll have the latest reports and news from our NBA insiders from around the league. MORE: Trade tracker | Trade grades | Outlook ...